Advertisement
Liver Complications in HIV-Infected Patients
- HIV Load Tied to Fibrosis Signal in Women Without Hepatitis or Alcohol Abuse (February 19, 2010)
From National AIDS Treatment Advocacy Project
- RNA Spikes Predict Heart Disease, CD4s Predict Liver and Kidney Disease (February 18, 2010)
From National AIDS Treatment Advocacy Project
- Safety Risk Associated With HIV Drug Videx (February 2, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Combining Sustiva + Viread May Increase Liver Risk, Case Reports Suggest (May 9, 2008)
In aidsmap.com
- Updates to Prezista (Darunavir) Tablets Labeling (March 11, 2008)
From U.S. Food and Drug Administration
- Non-Alcoholic Fatty Liver Disease Is Common in HAART-Experienced Patients; Several HIV- and Antiretroviral-Related Factors May Play Role (February 6, 2008)
From The Body PRO
- Immune Reconstitution May Trigger Hepatic Flares in HIV/Hepatitis B Coinfected Patients Starting HAART (February 5, 2008)
In 15th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Rapid Liver Fibrosis Occurring More Frequently Among HIV-Infected Men Newly Coinfected With Hepatitis C (February 4, 2008)
An interview with Daniel Fierer, M.D.
In 15th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- The Liver in HIV Disease (December 4, 2007)
Translating HIV research into practice.
From The Body PRO
- Tipranavir/Ritonavir-Associated Hepatotoxicity Common, But Resolves Over Time (September 30, 2006)
In 46th Interscience Conference on Antimicrobial Agents and Chemotherapy
- Antiretroviral Exposure Not Associated With Liver-Related Deaths in D:A:D Cohort (February 7, 2006)
In The 13th Conference on Retroviruses and Opportunistic Infections
Antiretroviral Therapy
Antiretroviral Therapy
E-Mail
Share